November 20, 2021 – Philips announced it signed an agreement to acquire Cardiologs, a France-based medical technology company focused on cardiac diagnostics using artificial intelligence (AI) and cloud technology. Cardiologs will further strengthen Philips’ cardiac monitoring and diagnostics offering with innovative software technology, electrocardiogram (ECG) analysis and reporting services. 

November 9, 2021 — Caption Health and Ultromics, developers of artificial intelligence (AI) to improve cardiac ultrasound diagnostics, announced a strategic partnership to accelerate cardiovascular disease detection and treatment for more patients in more accessible care settings. Together, the companies will jointly offer the Caption AI software platform alongside Ultromics’ EchoGo deep ultrasound analytics. 

November 9, 2021 — The COVID-19 (SARS-CoV-2) virus does not infect blood vessels, despite the high risk of blood clots to COVID-19 patients, researchers recently found at University of Queensland in Australia.

November 9 2021 — A new large-scale, real-world analysis of Centers for Medicare and Medicaid Services (CMS) outcomes data from of peripheral vascular interventions guided by intravascular ultrasound (IVUS) showed a  32% reduction in major adverse limb events, such as amputations, during lower extremity arterial intervention. 

November 8, 2021 – SWISS-APERO is the first randomized clinical trial comparing the Abbott Amulet left atrial appendage (LAA) transcatheter occluder with the new generation Boston Scientific Watchman FLX transcatheter occluder.

November 8, 2021 — Results from a clinical trial of the Edwards Lifesciences Evoque transcatheter tricuspid valve replacement system demonstrated favorable patient outcomes were sustained at six months. Results from the TRISCEND study, treating patients with tricuspid regurgitation, were presented during the late-breaking clinical science session at the 2021 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting of the Cardiovascular Research Foundation.

November 5, 2021 – An FDA-approved device used during cardiac cath lab procedures cut radiation exposure for cardiologists, nurses and other medical staff in half, according to a study conducted by Beaumont Health, the largest health system in Michigan. 

November 5, 2021 — In the worldwide effort to battle COVID-19 (SARS-CoV-2), researchers have often turned to medications used as therapies for other conditions in the hopes of finding ones that either kill the coronavirus or lessen the impacts from its infection. Recent small-sample studies (fewer than 200 patients) have suggested that statins, cholesterol-lowering drugs that lower levels of low-density lipoprotein (LDL), also may reduce the chances of severe disease or death from COVID-19.

Katherine Fornell, age 5, from suburban Chicago, receives her first dose of the COVID-19 vaccine during the first week it became available in the U.S. The FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine Oct. 29 for the prevention of COVID-19 in children 5 to 11 years of age. This was based on a safety review of more than 3,000 patients receiving the vaccine ages 5-11.

November 5, 2021 — The U.S. Food and Drug Administration (FDA) authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine Oct. 29 for the prevention of COVID-19 in children 5 to 11 years of age. 

The emergency use authorization (EUA) was based on the FDA’s evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine available to children in this age group.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now